Methenamine Hippurate

AvPAK🇺🇸 United States

FDA Page

Effective Date: Jan 9, 2024
Approval ID: b581b655-62a4-2aa9-e053-2a95a90aa823
Products: 1 registered
Version: 3

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

Methenamine Hippurate Tablets USP Rx Only To reduce the development of drug-resistant bacteria and maintain the effectiveness of methenamine hippurate and other antibacterial drugs, methenamine hippurate tablets USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

Quick Stats

Total Products1

Labelers2

Label Sections10

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.